Login to Your Account

Meeting the Bostonians: Stockholm delegation looks to Massachusetts

By Cormac Sheridan
Staff Writer

Tuesday, March 4, 2014
STOCKHOLM – Stockholm’s transition to a 21st century location for discovery science and drug development is under way in earnest, as two separate research partnerships between Astrazeneca plc and the Karolinska Institute start to gather momentum, while a preclinical drug development “toolbox,” aimed at academic researchers, will put out a call for its first projects in the coming months.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription